Market Research Logo

United States Sterilization Equipment Market Outlook to 2021

United States Sterilization Equipment Market Outlook to 2021

Summary

GlobalData’s new report, United States Sterilization Equipment Market Outlook to 2021, provides key market data on the United States Sterilization Equipment market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Chemical Sterilizers, Physical Sterilizers and Ultraviolet Sterilizers.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Sterilization Equipment market segments - Chemical Sterilizers, Physical Sterilizers and Ultraviolet Sterilizers.
  • Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Sterilization Equipment market.
  • Global corporate-level profiles of key companies operating within the United States Sterilization Equipment market.
  • Key players covered include Steris Corporation, Advanced Sterilization Products Services Inc., Getinge AB and others.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Sterilization Equipment Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Sterilization Equipment Market, United States
3.1 Sterilization Equipment Market, United States, Revenue ($m), 2007-2014
3.2 Sterilization Equipment Market, United States, Revenue ($m), 2014-2021
3.2.1 Chemical Sterilizers Market, United States, Revenue ($m), by Segment, 2007-2014
3.2.2 Chemical Sterilizers Market, United States, Revenue ($m), by Segment, 2014-2021
3.3 Sterilization Equipment Market, United States, Volume (Units), 2007-2014
3.4 Sterilization Equipment Market, United States, Volume (Units), 2014-2021
3.4.1 Chemical Sterilizers Market, United States, Volume (Units), by Segment, 2007-2014
3.4.2 Chemical Sterilizers Market, United States, Volume (Units), by Segment, 2014-2021
3.5 Sterilization Equipment Market, United States, Average Price ($), 2007-2021
3.6 Sterilization Equipment Market, United States, Distribution Share by Revenue ($m), 2013-2014
3.7 Sterilization Equipment Market, United States, Company Share by Revenue ($m), 2014
4 Overview of Key Companies in United States, Sterilization Equipment Market
4.1 Steris Corporation
4.1.1 Company Overview
4.2 Advanced Sterilization Products Services Inc.
4.2.1 Company Overview
4.3 Tuttnauer USA Co. Ltd.
4.3.1 Company Overview
4.4 Getinge AB
4.4.1 Company Overview
4.5 3M Health Care Ltd.
4.5.1 Company Overview
4.6 Belimed Sauter AG
4.6.1 Company Overview
5 Sterilization Equipment Market Pipeline Products
6 Financial Deals Landscape
6.1 Acquisition
6.1.1 Steris to Acquire General Econopak for USD175 Million
6.2 Asset Transactions
6.2.1 Crosstex International to Acquire Sterility Assurance Products Division of North American Science Associates
6.2.2 Xellia Pharma Acquires Manufacturing Facilities from Hikma Pharma
6.2.3 Medline Industries Acquires Assets of SwabFlush from ICU Medical for USD27 Million
6.3 Equity Offerings
6.3.1 Pure Bioscience Raises USD6 Million in Private Placement of Shares
6.4 Private Equity
6.4.1 RoundTable Healthcare Acquires TIDI Products from J.H. Whitney
7 Recent Developments
7.1 Corporate Communications
7.1.1 Sep 29, 2015: Anacor Pharmaceuticals Announces Presentations of Crisaborole Topical Ointment, 2% Phase 3 Pivotal Data at Two Upcoming Medical Conferences
7.1.2 Aug 07, 2015: Cantel Medical Appoints David Rosen as President, Asia Pacific and Emerging Markets
7.1.3 Jul 31, 2015: Pure Bioscience Announces Restructuring Of Its Finance Department
7.1.4 Jun 29, 2015: Cantel Medical Appoints David C. Hemink as President, Medivators and Michael G. Spicer as President, Americas Sales and Global Service
7.1.5 Jun 19, 2015: PuriCore announces Board Changes
7.1.6 Jun 03, 2015: Puritan Welcomes New Director of Sales, West Coast
7.1.7 Mar 19, 2015: Cantel Medical Announces Appointment Of Dr. Laura Forese To Its Board Of Directors
7.1.8 Mar 10, 2015: Maetrics announces new president
7.2 Financial Announcements
7.2.1 Dec 10, 2015: Cantel Medical Reports Record Results For The First Quarter Ended October 31, 2015
7.2.2 Dec 08, 2015: Studies Demonstrate Broadening Clinical Utility of bioTheranostics’ Breast Cancer Index Molecular Test in the Extended Endocrine Therapy Setting
7.2.3 Dec 08, 2015: Medovex Completes Multi-Unit Streamline IV Suspension System Sale to Major Regional Hospital
7.2.4 Dec 07, 2015: Foundation Medicine Announces Presentations at the 2015 San Antonio Breast Cancer Symposium
7.2.5 Dec 07, 2015: Agendia’s MammaPrint and BluePrint Breast Cancer Tests to Be Highlighted at San Antonio Symposium
7.2.6 Dec 04, 2015: BioVentrix Announces Milestone Achievement of its First Interventional Heart Failure Procedure for LV Volume Reduction in a Pre-Clinical Model
7.2.7 Dec 04, 2015: Cerus Announces Mississippi Valley Regional Blood Center Enters Into Agreement for the Use of INTERCEPT Platelets and Plasma
7.2.8 Nov 10, 2015: Independent study of Cloud DX wrist cuff blood pressure monitor shown to be accurate compared to gold-standard measures by intraarterial pressure catheter in clinical setting
7.2.9 Nov 05, 2015: Atrion Reports Third Quarter 2015 Results
7.2.10 Sep 29, 2015: Motif Announces Presentation of Two Posters on Iclaprim at ID Week 2015
7.2.11 Sep 29, 2015: Cantel Medical Reports Record Results For The Fourth Quarter Ended July 31, 2015
7.2.12 Aug 04, 2015: Atrion Reports Second Quarter 2015 Results
7.2.13 Jul 29, 2015: Hospira Reports Second-Quarter 2015 Results
7.2.14 Jun 11, 2015: PURE Bioscience Reports 2015 Fiscal Third Quarter and Nine-Month Financial Results
7.2.15 Jun 01, 2015: OncoGenex Announces Data from Borealis-1 Trial Showing Clinical Benefit with Apatorsen in Metastatic Bladder Cancer
7.2.16 May 06, 2015: Atrion Reports First Quarter Results
7.2.17 Apr 28, 2015: Hospira Reports First-Quarter 2015 Results
7.2.18 Apr 27, 2015: Medtronic Announces Consent Decree with FDA for the Synchromed Drug Infusion System
7.2.19 Apr 16, 2015: Ethicon Receives Prestigious Award for ENSEAL G2 Articulating Tissue Sealer Innovation in Design, Sustainability Improvements
7.2.20 Mar 04, 2015: PURE Bioscience Reports 2015 Fiscal Second Quarter and Six-Month Financial Results
7.2.21 Feb 23, 2015: Atrion Reports Fourth Quarter and Full Year 2014 Results
7.2.22 Feb 20, 2015: Medigene receives positive decision on marketing authorisation for Veregen in 8 additional European countries
7.3 Legal And Regulatory
7.3.1 Jun 24, 2015: TOMI Receives EPA Registration for Its Patented BIT Technology
7.3.2 May 01, 2015: Hospira Statement On FDA's Final Biosimilar Guidance Documents
7.3.3 Apr 13, 2015: Hope for Greater Access for Patients to Biosimilar Medicines
7.3.4 Feb 27, 2015: Hospira Provides Update On FDA Inspection At Its Facilities In US And India
7.4 Other Significant Developments
7.4.1 Jan 12, 2016: New PDI Visual Resource Highlights How Proper Disinfection Can Reduce Central Line-associated Bloodstream Infections
7.4.2 Sep 28, 2015: Esperion Therapeutics Provides Further Updates on ETC-1002 Global Phase 3 Strategy Following Receipt of End-of-Phase 2 Meeting Minutes
7.4.3 Jul 16, 2015: Delafield Solutions Joins With Pocono Medical Center to Demonstrate Effectiveness of Continuous Area Disinfection
7.4.4 Jun 03, 2015: Halyard Health Signs First GPO Contract as Independent Company
7.4.5 Mar 31, 2015: Halyard Health Signs First GPO Contracts as Independent Company: Leader in Sterilization Wrap, Facial Protection and Respiratory Health Awarded Contract with HealthTrust
7.4.6 Mar 03, 2015: Atrion Declares Quarterly Cash Dividend
7.4.7 Feb 19, 2015: Getinge Receives Double iF Design Award for the Innovative User-Interface CENTRIC and Product Design of Getinge ProSeal
7.5 Product News
7.5.1 Jan 20, 2016: rfXcel Transforms Global Compliance and Serialization With Release of Next Generation Platform
7.5.2 Nov 24, 2015: NuShield Provides Health Care Facilities with Germ Fighting Solution Technology
7.5.3 Jun 26, 2015: First Hospital Light Fixture to Kill Bacteria Safely and Continuously Becomes Commercially Available in U.S. and Canada
7.5.4 Jun 17, 2015: Puritan Medical Products Company updates Customers with more details about the final decision of the European Patent Office on Copan's European Patent EP 1 608 268 B1
7.5.5 Jun 15, 2015: 3M/Ivera Medical & Catheter Connections Settle Patent Infringement Litigation
7.5.6 Apr 15, 2015: Crosstex/SPSmedical Launches SANI ProZyme Enzymatic Detergent and SANI Glut Glutaraldehyde 3% Solution
7.6 Strategy And Business Planning
7.6.1 Sep 28, 2015: Clinical Data Presented On Binimetinib And Encorafenib In Melanoma
7.6.2 Jun 08, 2015: Massachusetts Life Sciences Center and Dana-Farber Cancer Institute announce official opening of Dana-Farber's Molecular Cancer Imaging Facility
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Company Share Analysis
8.1.5 Distribution Share Analysis
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer
1.1 List of Tables
Table 1: Sterilization Equipment Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
Table 2: Sterilization Equipment Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
Table 3: Chemical Sterilizers Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
Table 4: Chemical Sterilizers Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
Table 5: Sterilization Equipment Market, United States, Volume (Units), Historic, 2007-2014
Table 6: Sterilization Equipment Market, United States, Volume (Units), Forecast, 2014-2021
Table 7: Chemical Sterilizers Market, United States, Volume (Units), Historic, 2007-2014
Table 8: Chemical Sterilizers Market, United States, Volume (Units), Forecast, 2014-2021
Table 9: Sterilization Equipment Market, United States, Average Price ($), Historic, 2007-2014
Table 10: Sterilization Equipment Market, United States, Average Price ($), Forecast, 2014-2021
Table 11: Sterilization Equipment Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014
Table 12: Sterilization Equipment Market, United States, Company Share by Revenue ($m), USD Constant, 2014
Table 13: Sterilization Equipment Market Pipeline Products
Table 14: Steris to Acquire General Econopak for USD175 Million
Table 15: Crosstex International to Acquire Sterility Assurance Products Division of North American Science Associates
Table 16: Xellia Pharma Acquires Manufacturing Facilities from Hikma Pharma
Table 17: Industries Acquires Assets of SwabFlush from ICU Medical for USD27 Million
Table 18: Pure Bioscience Raises USD6 Million in Private Placement of Shares
Table 19: RoundTable Healthcare Acquires TIDI Products from J.H. Whitney
1.2 List of Figures
Figure 1: Sterilization Equipment Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
Figure 2: Sterilization Equipment Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
Figure 3: Chemical Sterilizers Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
Figure 4: Chemical Sterilizers Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
Figure 5: Sterilization Equipment Market, United States, Volume (Units), Historic, 2007-2014
Figure 6: Sterilization Equipment Market, United States, Volume (Units), Forecast, 2014-2021
Figure 7: Chemical Sterilizers Market, United States, Volume (Units), Historic, 2007-2014
Figure 8: Chemical Sterilizers Market, United States, Volume (Units), Forecast, 2014-2021
Figure 9: Sterilization Equipment Market, United States, Company Share (%) 2014

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report